Skip to content

Pilot Study of cNEP for the Treatment of Snoring

Pilot Study to Assess the Effectiveness and Safety of Continuous Negative External Pressure (cNEP) in Reducing Respiratory Sounds in Individuals With Chronic Snoring

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02767843
Enrollment
4
Registered
2016-05-10
Start date
2016-05-31
Completion date
2016-12-31
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Snoring

Brief summary

This pilot study will examine the efficacy and safety of continuous negative external pressure (cNEP) for the treatment of chronic snoring in people without obstructive sleep apnea.

Interventions

DEVICEcontinuous negative external pressure (cNEP)

soft silicone collar placed on the anterior neck, to which a negative pressure is introduced

Sponsors

Sommetrics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* sleep test within the previous six months that shows snoring of at least 30 dB for at least 30% of total sleep time * AHI \< 10/hr

Exclusion criteria

* previous neck surgery or radiation * carotid artery disease * serious medical or psychiatric illness * pregnancy * silicone allergy * excessive use of alcohol or sedating drugs

Design outcomes

Primary

MeasureTime frameDescription
Responseone nightsnoring decreased by \<50% from baseline
Adverse Eventsone nightall adverse events

Secondary

MeasureTime frameDescription
Complete Responseone nightsnoring for \< 5% of total sleep tim

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment
continuous negative external pressure (cNEP) at various negative pressures continuous negative external pressure (cNEP): soft silicone collar placed on the anterior neck, to which a negative pressure is introduced
4
Total4

Baseline characteristics

CharacteristicTreatment
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Age, Continuous42 years
Region of Enrollment
United States
4 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

Adverse Events

all adverse events

Time frame: one night

Population: All four participants were analyzed for adverse events. No participants could be analyzed for efficacy outcomes because of technical difficulties with the measurement instruments.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SubjectsAdverse Events1 Participants
Primary

Response

snoring decreased by \<50% from baseline

Time frame: one night

Population: Technical problems with the measurement instruments meant that no analyzable data were collected.

Secondary

Complete Response

snoring for \< 5% of total sleep tim

Time frame: one night

Population: Insufficient enrollment to permit analysis.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026